Elderly patients with advanced colorectal cancer: Tolerability and activity of chemotherapy

Tumori

Volumn 91, Issue 6, 2005, Pages 463-466

  Berardi, Rossana ^a,c   Saladino, Tiziana ^b   Mari, Davide ^b   Silva, Rosa Rita ^b   Scartozzi, Mario ^a   Verdecchia, Lorena ^a   Onofri, Azzurra ^a   Cascinu, Stefano ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Medical Oncology   (Italy)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

Chemotherapy; Colorectal cancer; Elderly

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DRUG INFUSION; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; HUMAN; LEUKOPENIA; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PARESTHESIA; PERIPHERAL NEUROPATHY; STOMATITIS; THROMBOCYTOPENIA; TOXICITY; TREATMENT OUTCOME; VOMITING;

EID: 32844461849     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160509100603     Document Type: Article

References (21)

1. Furner SE, Brody JA, Jankowski LM: Epidemiology and aging. In: Geriatric Medicine (3rd edn), Cassel CK, Cohen HJ, Larson EB, et al (Eds), pp 37-43, Springer, New York, 1997.
2. Mor V, Masterson-Allen S, Goldeberg RJ, Cummings FJ, Glicksman AS, Fretwell MD: Relationship between age at diagnosis and treatment received by cancer patients. J Am Geriatric Soc, 33: 585-589, 1985.
3. Sundararajan V, Grann VR, Neugut AI, Irving H: Population based variation in the use of chemotherapy for colorectal cancer in the elderly. Proc Am Soc Clin Oncol, Abstract no. 1598, 1999.
4. Davies I: Theories and general principles of aging. In: Textbook of Geriatric Medicine and Gerontology (4th edn.), Brckle-Burst JC, Tallis RC, Fillit HM (Eds), pp 26-608, Churcill Livingstone, Edinburgh, 1992.
5. Honecker F, Kohne CH, Bokemeyer C: Colorectal cancer in the elderly: is palliative chemotherapy of value? Drugs Aging, 20: 1-11, 2003.
6. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA: Representation of older patients in cancer treatment trials. Cancer, 74: 2208-2214, 1994.
7. Stein BN, Petrelli NJ, Dougless HO, Driscoll DL, Arcangeli G, Meropol NJ: Age and sex are independent predictors of 5-fluorouracil toxicity: analysis of large scale phase III trial. Cancer, 75: 11-17, 1995.
8. Wasserman E, Sutherland W, Cvitkovic E: Irinotecan plus oxaliplatin: a promising combination for advanced colorectal cancer. Clin Colorectal Cancer, 1: 149-153, 2001.
9. Bollina R, Belloni P, Toniolo D, Cozzi C, Alfieri E, Beretta G, Clerici MP: Phase II evaluation of weekly oxaliplatin (OXA) and irinotecan (IRI)- OXIRI - as second line chemotherapy (CT) for advanced colorectal cancer (ACRC) in geriatric patients (pts). Proc Am Soc Clin Oncol, Abstrat no. 2849, 2002.
10. Raymond E, Buquet-Fagot C, Djelloul S, Mester J, Cvitkovic E, Allain P, Louvet C, Gespach C: Antitumor activity of oxaliplatin in combination with 5-fluoouracil and the thymidylate synthase inhibitor AG337 in human colon, breast, and ovarian cancers. Anticancer Drugs, 8: 876-885, 1997.
11. Beretta M, Bonadonna A, Rupolo M, Frustaci S, Bearz A, Sorio R, Freschi A, Scalone S, Michieli M, Spina M, Tirelli U, Colussi A, Cartei G: Comparison between elderly and non elderly patients (Pts) of efficacy and tolearability of FOL-FOX schedule in advanced colorectal cancer. Proc Am Soc Clin Oncol, Abstract no. 2195, 2001.
12. Vamvakas L, Kakolyris S, Kouroussis C, Kandilis K, Mavroudis D, Androulakis N, Kalbakis K, Sarra E, Souglakos J, Georgoulias VO: Irinotecan in combination with infusional 5-fluorouracile plus leucovorin (de Gramont regimen) as first-line treatment in advanced colorectal cancer: A multicenter phase II study. Am J Clin Oncol, 25: 65-70, 2002.
13. De Gramont A, Vignoud J, Tournigand C, Louvet C, Andre T, Varette C, Raymond C, Moreau S, Le Bail N, Krulik M: Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer, 33: 214-219, 1997.
14. Levi F, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, Chollet P, Garufi C, Itzbaki M, Dogliotti L: Chronomodulated versus fixed infusion rate delivery of ambulatory chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with colorectal cancer metastases: A randomized multinstitutional trial. J Natl Cancer Inst, 86: 1608-1617, 1994.
15. De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes A, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Marvan F, Bonetti A: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol, 18: 2938-2947, 2000.
16. Begg CB, Carbone PP: Clinical trials and drug toxicity in the elderly: the experience of the Eastern Cooperative Oncology Group. Cancer, 53: 1986-1992, 1983.
17. Cascinu S, Del Ferro E, Catalano G: Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer. Am J Clin Oncol, 19: 371-374, 1996.
18. Popescu RA, Norman A, Ross PJ, Parikh B, Cunningham D: Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol, 17: 2412-2418, 1999.
19. Aparicio T, Desramè J, Lecomte T, Mitry E, Belloc J, Etienney I, Montembault S, Vayre I, Locher C, Ezenfis J, Artru P, Mabro M, Dominguez S: Oxaliplatin or irinotecan based chemotherapy for metastatic colorectal cancer in the elderly. Br J Cancer, 89: 1439-1444, 2003.
20. Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, La Bianca R., Haller DG, Shepherd LE, Seiz JF, Francini G: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med, 345: 1091-1097, 2001.
21. Folprecht G, Cunninghanm D, Ross P, Glimelius B, Di Costanzo F, Wils J, Scheitha Rougier P, Aranda E, Hecker H, Kohne CH: Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol, 15: 1330-1338, 2004.